NBIX Institutional Ownership

NEUROCRINE BIOSCIENCES INC

Latest close $161.50 as of Aug 5, 2026

Create account to watch
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.
Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 27, 2026
Public consensus preview Accumulation leaning 64/100 institutional research score
3 tracked institutions Latest filing Jul 27, 2026

1 accumulating across 1 comparable institution.

Accumulating1
Unchanged0
Reducing0
Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$122.14 52-week high$171.50
Latest close $161.50 79.7% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026
JPMorgan Chase / Asset Management Jul 27, 2026 filed
State Street Feb 5, 2025 filed
BlackRock Legacy Jan 23, 2024 filed
Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 4 parsed filing(s) · 1 older require more history access
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
JPMorgan Chase / Asset Management CIK0000019617 Jun 30, 2026 observed Jul 27, 2026 filed · 27d Schedule 13G amendment Reported accumulation 6.3M +1.1M 12.00% 0.00 pts $168.54 $176.41 $161.50
JPMorgan Chase / Asset Management CIK0000019617 Dec 31, 2025 observed Jan 21, 2026 filed · 21d Initial Schedule 13G Initial Schedule 13G 5.2M 12.00% $141.83 $135.41 $161.50
State Street CIK0000093751 Dec 31, 2024 observed Feb 5, 2025 filed · 36d Initial Schedule 13G Initial Schedule 13G 4.9M 12.00% $136.50 $151.20 $161.50
Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

COGT COGENT BIOSCIENCES INC 64/100 Accumulation leaning ELDN ELEDON PHARMACEUTICALS INC 64/100 Accumulation leaning PNTG PENNANT GROUP INC/THE 64/100 Accumulation leaning CVBF CVB FINANCIAL CORP 64/100 Accumulation leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026